GVB Biopharma — Form D
GVB Biopharma of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-27. The offering totals $8.0M, of which $7.6M was reported sold. Industry: Manufacturing.
Offering
- Filed: 2020-11-27
- Form: D
- Accession: 0001809889-20-000003
- Industry: Manufacturing
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $7.6M
- Remaining: $394K
- Minimum investment: $500K
- Investors: 28
- Date of first sale: 2020-11-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-381622
Issuer
- Name: GVB Biopharma
- CIK: 0001809889
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2019
- Address: 4456 E. CRAIG RD., LAS VEGAS, NV, 89115
- Phone: 2139261580
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Theodore Swindells | Director | Las Vegas, NV |
| William Spiegel | Director | Las Vegas, NV |
| William Spiegel | Executive Officer | Las Vegas, NV |
| Jack Feldman | Director | Las Vegas, NV |
| Jack Feldman | Executive Officer | Las Vegas, NV |
| Phillip Swindells | Director | Las Vegas, NV |
| Phillip Swindells | Executive Officer | Las Vegas, NV |
Other filings by this issuer (5)
More